REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday preview: Fedspeak, GSK in the spotlight

Tue, 08th Feb 2022 15:00

(Sharecast News) - Inverstors' attention on Wednesday will be on appearances by two top US central bank officials, whose words will be carefully parsed for any policy relevant remarks.




Federal Reserve Governor Michelle Bowman is due to speak to a community bankers association at 1530 GMT, followed by Cleveland Fed President, Loretta Mester, at a virtual event on the outlook for the economy and monetary policy at 1700 GMT.

Across the Channel meanwhile, the market spotlight will be on foreign trade figures out of Germany covering and industrial production data for Italy, both covering the month of December.

Further afield, rate-setters in India and Thailand are due to meet to decide on policy.

In China, the country's central bank may release money supply data for January.

No major economic releases are scheduled in the UK.

For GlaxoSmithKline's fourth quarter, UBS analyst Laura Sutcliffe has penciled-in a 7% jump in sales versus a year earlier to reach £9.33bn.

Core earnings before interest and taxes meanwhile were pegged at roughly £1.92bn, for a 9% rise and core earnings per share of 25p (consensus: 23p).

The analyst said that the recovery path for sales of the company's treatment against shingles, Shingrix, would be key.

Her estimates called for quarterly Shingrix sales of approximately £565m.

She further estimated that the current share price was discounting a roughly £50bn enterprise value for GSK's Consumer Health arm, which was due to be spun out mid year and a stub biopharma business trading on a core price-to-earnings multiple of 11-12 times.

Excluding Covid solutions, she expected the stub business to generate earnings per share of around 96.0p.

Wednesday 09 February

INTERIMS

Barratt Developments, Dunelm Group, PZ Cussons

INTERIM DIVIDEND PAYMENT DATE

Crystal Amber Fund Ltd., Panther Securities

QUARTERLY PAYMENT DATE

British American Tobacco

INTERNATIONAL ECONOMIC ANNOUNCEMENTS

Balance of Trade (GER) (07:00)

Crude Oil Inventories (US) (15:30)

Current Account (GER) (07:00)

MBA Mortgage Applications (US) (12:00)

Wholesales Inventories (US) (15:00)

Q4

GlaxoSmithKline, Lancashire Holdings Limited

GMS

Industrials Reit Limited

FINALS

Lancashire Holdings Limited, Smurfit Kappa Group (CDI)

AGMS

Contango Holdings , Euromoney Institutional Investor, Finsbury Growth & Income Trust, Grainger, Inspirit Energy Holdings, JPMorgan Asia Growth & Income, Oxford Metrics, Schroder UK Mid Cap Fund

TRADING ANNOUNCEMENTS

Discoverie Group, Grainger

UK ECONOMIC ANNOUNCEMENTS

Retail Sales (00:01)

FINAL DIVIDEND PAYMENT DATE

Brewin Dolphin Holdings, Future



More News
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.